Holding(s) in Company

For immediate release 

7 October 2009

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Neuropharm Group plc

2. Reason for the notification  

Other (please specify): Movement of holdings between Direct and Indirect

Yes

3. Full name of person(s) subject to the notification obligation:

Lloyds Banking Group plc

4. Full name of shareholder(s) (if different from 3.):

See Section 9

5. Date of the transaction and date on which the threshold is crossed or reached:

2 October 2009

6. Date on which issuer notified:

6 October 2009

7. Threshold(s) that is/are crossed or reached:

Direct/Indirect remains above 9% (Direct to increase to above 4% and Indirect decrease to below 6%)

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares Direct

Number of voting rights

% of voting rights

Direct

Indirect

Direct

Indirect

GB00B1NPJJ01

3,031,093

3,031,093

1,328,393

1,328,393

1,708,222

4.212%

5.417%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument 

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted 

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Number of voting rights instrument refers to

% of voting rights 

Total (A+B+C)

Number of voting rights

% of voting rights

3,036,615

9.629%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

3,036,607 shares (9.629%) are under the control of Insight Investment Management (Global) Limited, a wholly owned subsidiary of Insight Investment Management Limited, a wholly owned subsidiary of HBOS Insurance & Investment Group Limited, a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc (Direct/ Indirect Interests). 

Within these holdings 22,658 shares (0.072%) are managed on behalf of Clerical Medical Managed Funds Limited a wholly owned subsidiary of Clerical Medical Investment Group Limited, and a further 1,305,727 shares (4.140%) are managed on behalf of Clerical Medical Investment Group Limited, a wholly owned subsidiary of HBOS Financial Services Limited, a wholly owned subsidiary of HBOS Insurance & Investment Group Limited a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc. These holdings are therefore disclosed as an overall Direct Interest.

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Notification using the Total Voting Rights figure of 31,536,697

14. Contact name:

Kenny Melville

15. Contact telephone number:

0131 243 5301